Search

> Historical archive: This is the software list from our earlier website. It describes the tools and hosting used then, rather than the current site. ## Open Source Tools, Credits, and Tech Stack Phage Directory runs on a lot of software,

These tools supported earlier versions of Phage Directory. Their interactive forms and external database workflows are retired. ## RIS to Library The old RIS utility converted RIS bookmarks exported from Meta.org into CSV for Airtable i

> Historical archive: Names, roles, affiliations and plans below describe the earlier volunteer page. They have not been refreshed into current profiles. We preserve these credits with thanks to everyone who contributed. We have some amazi

The Phage Directory Slack community is retired, and invitations are no longer available. Looking for phage therapy? Read the therapy guide. You can still follow research, news, and opportunities in Capsid & Tail.

We are no longer accepting paid sponsorships. Thank you to everyone who supported Phage Directory and Capsid & Tail. Past sponsor credits remain with their original issues.

A starting point for learning about phage therapy and discussing research-based options with your care team. Phage Directory is a research-focused information resource. We do not provide treatment or accept patients. What is phage therapy?

Greetings from the Lieberman lab at MIT! To understand the role of phage predation on skin colonization and diversity, we characterize bacteria and phages from longitudinal facial samples using genomics and high-throughput experiments. Our

Currently bioprospecting for new phages that target multi drug-resistant Pseudomonas bacteria. Bollyky Lab

University of Isfahan; U of Isfahan Dept. of Biology Lab

Undergraduate Biotechnology student at University of Aleppo. I've been working on isolating phages from local environmental samples, and looking forward to introduce phage therapy as a real alternative therapy in my country. I'm also intere

J'ai fait dans mon mémoire de fin d'études un isolement et sélection de bactéries multirésistantes à l'hôpital de kolea et j'ai isolé les phages de ces bactéries des eaux usées au centre de recherche physico-chimique du CRAPC à bousmail, po

Abiola is a Postdoctoral Associate at Texas A&M University, USA. His current research focuses on deciphering the molecular mechanisms of host-induced metronidazole resistance in Clostridium difficile. Prior to this, he had worked on dissect

I am interested in the host-pathogen interactions of bacteria and their phages. In graduate school, I studied how phages use anti-CRISPRs to protect themselves from the bacterial CRISPR-Cas immune system. UCSF; Bondy-Denomy lab

I'm a molecular microbiologist and I've spent my academic career investigating biofilm formation and later Type VI Secretion System and the molecular and biochemical workings of these systems. I then moved to industry research on developmen

I am a research fellow funded through New Science, working in the Garner Lab at Harvard on collective responses to phage infection in biofilms, focusing specifically on bioelectric communication and how that may impact anti-phage defense. H

Worked with various E. coli strains and cultured coliphage T4 to target those strains in an independent research project. Wrote a general review article about phage therapy. Currently studying the potential of using phage to address seconda

Lund University; Hatti-Kaul Lab

University of Aveiro; Laboratório de Microbiologia Aplicada

Texas A&M University; Center for Phage Technology

My research focuses on the discovery of new antiphage molecules, but I am interested in anything phage-related—from the most fundamental aspects to clinical applications. Forschungszentrum Jülich; Frunzke Lab